1. Vink R, Nechifor M. Magnesium in the central nervous system. Adelaide: University of Adelaide Press; 2011.
2. Wolahan SM, Hirt D, Glenn TC. Translational metabolomics of head injury: exploring dysfunctional cerebral metabolism with ex vivo NMR spectroscopy-based metabolite quantification. In: Kobeissy FH, editor. Brain neurotrauma: molecular, neuropsychological, and rehabilitation aspects. Boca Raton, FL: CRC Press/Taylor & Francis; 2015.
6. Maas AI, Murray GD. Magnesium for neuroprotection after traumatic brain injury. Lancet Neurol 2007;6:20-1.
7. Kramer AH, Couillard P. Neurocritical care: a growing international collaborative. Neurocrit Care 2020;32:80-3.
8. Porcayo-Liborio S, Rivera-Durón E, Orta-San-Juan D. The evolution of neuro-critical care in Mexico. Rev Mex Anest 2010;33:50-5.
9. Suarez JI, Zaidat OO, Suri MF, Feen ES, Lynch G, Hickman J, et al. Length of stay and mortality in neurocritically ill patients: impact of a specialized neurocritical care team. Crit Care Med 2004;32:2311-7.
10. Varelas PN, Conti MM, Spanaki MV, Potts E, Bradford D, Sunstrom C, et al. The impact of a neurointensivist-led team on a semiclosed neurosciences intensive care unit. Crit Care Med 2004;32:2191-8.
12. Amory CF, Varelas PN. Magnesium and hydrogen in subarachnoid hemorrhage: is neuroprotection finally a reality? Stroke 2021;52:28-30.
14. van den Bergh WM, Dijkhuizen RM, Rinkel GJ. Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 2004;17:301-13.
15. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011-5.
16. Venkatasubba Rao CP, Suarez JI. Magnesium and neuroprotection in subarachnoid haemorrhage. Lancet 2012;380:9-11.
17. Wong GK, Poon WS. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy. Acta Neurochir Suppl 2013;115:45-8.
18. Altman D, Carroli G, Duley L, Farrell B, Moodley J, Neilson J, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie trial: a randomised placebo-controlled trial. Lancet 2002;359:1877-90.
19. Belfort MA, Anthony J, Saade GR, Allen JC Jr; Nimodipine Study Group. A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003;348:304-11.
20. McLean RM; Nimodipine Study Group. Magnesium and its therapeutic uses: a review. Am J Med 1994;96:63-76.
21. McKee JA, Brewer RP, Macy GE, Borel CO, Reynolds JD, Warner DS. Magnesium neuroprotection is limited in humans with acute brain injury. Neurocrit Care 2005;2:342-51.
22. Li W, Bai YA, Li YJ, Liu KG, Wang MD, Xu GZ, et al. Magnesium sulfate for acute traumatic brain injury. J Craniofac Surg 2015;26:393-8.
25. Barbosa FT, Barbosa LT, Jucá MJ, Cunha RM. Applications of magnesium sulfate in obstetrics and anesthesia. Rev Bras Anestesiol 2010;60:104-10.
28. Stangherlin A, O'Neill JS. Signal transduction: magnesium manifests as a second messenger. Curr Biol 2018;28:R1403-5.
29. Seyama T, Kamei Y, Iriyama T, Imada S, Ichinose M, Toshimitsu M, et al. Pretreatment with magnesium sulfate attenuates white matter damage by preventing cell death of developing oligodendrocytes. J Obstet Gynaecol Res 2018;44:601-7.
30. Sun Q, Weinger JG, Mao F, Liu G. Regulation of structural and functional synapse density by L-threonate through modulation of intraneuronal magnesium concentration. Neuropharmacology 2016;108:426-39.
31. Spasov AA, Iezhitsa IN, Kravchenko MS, Kharitonova MV. Features of central neurotransmission in animals in conditions of dietary magnesium deficiency and after its correction. Neurosci Behav Physiol 2009;39:645-53.
34. Ortega-Sierra MG, Durán-Daza RM, Carrera-Patiño SA, Rojas-Nuñez AX, Charry-Caicedo JI, Lozada-Martínez ID. Neuroeducation and neurorehabilitation in the neurosurgical patient: programs to be developed in Latin America and the Caribbean. J Neurosurg Sci 2021 Jun 10 [Epub].
https://doi.org/10.23736/S0390-5616.21.05439-4.
35. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004;45:545-52.
36. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25.
37. Abbott NJ, Romero IA. Transporting therapeutics across the blood-brain barrier. Mol Med Today 1996;2:106-13.
38. Allsop TF. Transfer of magnesium across the perfused choroid plexus of sheep. Aust J Biol Sci 1986;39:161-9.
39. Allsop TF, Pauli JV. Magnesium concentrations in the ventricular and lumbar cerebrospinal fluid of hypomagnesaemic cows. Res Vet Sci 1985;38:61-4.
40. Agre P, Preston GM, Smith BL, Jung JS, Raina S, Moon C, et al. Aquaporin CHIP: the archetypal molecular water channel. Am J Physiol 1993;265(4 Pt 2):F463-76.
41. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003;4:991-1001.
43. Bara M, Guiet-Bara A. Potassium, magnesium and membranes: review of present status and new findings. Magnesium 1984;3:215-25.
44. Martin KJ, González EA, Slatopolsky E. Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol 2009;20:2291-5.
45. Panahi Y, Mojtahedzadeh M, Najafi A, Ghaini MR, Abdollahi M, Sharifzadeh M, et al. The role of magnesium sulfate in the intensive care unit. EXCLI J 2017;16:464-82.
46. Gragossian A, Bashir K, Friede R. Hypomagnesemia. Treasure Island, FL: StatPearls Publishing; 2021.
48. Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg 2019;74:41-7.
49. Broman M, Hansson F, Klarin B. Analysis of hypo- and hypermagnesemia in an intensive care unit cohort. Acta Anaesthesiol Scand 2018;62:648-57.
50. Cascella M, Vaqar S. Hypermagnesemia. Treasure Island, FL: StatPearls Publishing; 2021.
51. Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 2003;4:195-206.
52. Schelling JR. Fatal hypermagnesemia. Clin Nephrol 2000;53:61-5.
53. Bokhari SR, Siriki R, Teran FJ, Batuman V. Fatal hypermagnesemia due to laxative use. Am J Med Sci 2018;355:390-5.
54. Gomes D, Pimentel J, Bentes C, Aguiar de Sousa D, Antunes AP, Alvarez A, et al. Consensus protocol for the treatment of super-refractory status epilepticus. Acta Med Port 2018;31:598-605.
55. Zeiler FA, Matuszczak M, Teitelbaum J, Gillman LM, Kazina CJ. Magnesium sulfate for non-eclamptic status epilepticus. Seizure 2015;32:100-8.
57. Macías-Ruíz VS, Cordero-Pérez MB, Vásquez-Cedeño DA, Saltos-Mata F. Factors associated with mortality of spontaneous intraparenchymal cerebral hemorrhage in patients over 50 years of age who attended the teodoro maldonado carbo hospital during the year 2017. Rev Ecuat Neurol 2019;28:10-5.
58. Jafari M, Di Napoli M, Lattanzi S, Mayer SA, Bachour S, Bershad EM, et al. Serum magnesium level and hematoma expansion in patients with intracerebral hemorrhage. J Neurol Sci 2019;398:39-44.
60. Mejía C JA, Niño de Mejía MC, Ferrer Z LE, Cohen MD. Cerebral vasospasm secondary to subarachnoid hemorrhage due to ruptured intracerebral aneurysm. Rev Colomb Anesthesiol 2007;35:143-62.
61. Soliman R, Zohry G. Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study. Braz J Anesthesiol 2019;69:64-71.
62. Findlay JM, Nisar J, Darsaut T. Cerebral vasospasm: a review. Can J Neurol Sci 2016;43:15-32.
64. Lai TW, Zhang S, Wang YT. Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol 2014;115:157-88.
65. Saver JL, Kidwell C, Eckstein M, Starkman S; FAST-MAG Pilot Trial Investigators. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 2004;35:e106-8.
67. Shkirkova K, Starkman S, Sanossian N, Eckstein M, Stratton S, Pratt F, et al. Paramedic initiation of neuroprotective agent infusions: successful achievement of target blood levels and attained level effect on clinical outcomes in the FAST-MAG pivotal trial (field administration of stroke therapy-magnesium). Stroke 2017;48:1901-7.
68. Pan WH, Lai YH, Yeh WT, Chen JR, Jeng JS, Bai CH, et al. Intake of potassium- and magnesium-enriched salt improves functional outcome after stroke: a randomized, multicenter, double-blind controlled trial. Am J Clin Nutr 2017;106:1267-73.
70. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010;41:921-6.
71. Takeuchi S, Kumagai K, Toyooka T, Otani N, Wada K, Mori K. Intravenous hydrogen therapy with intracisternal magnesium sulfate infusion in severe aneurysmal subarachnoid hemorrhage. Stroke 2021;52:20-7.
73. Xu R, Wang L, Sun L, Dong J. Neuroprotective effect of magnesium supplementation on cerebral ischemic diseases. Life Sci 2021;272:119257.
74. Lee JS, Han YM, Yoo DS, Choi SJ, Choi BH, Kim JH, et al. A molecular basis for the efficacy of magnesium treatment following traumatic brain injury in rats. J Neurotrauma 2004;21:549-61.
75. Stippler M, Fischer MR, Puccio AM, Wisniewski SR, Carson-Walter EB, Dixon CE, et al. Serum and cerebrospinal fluid magnesium in severe traumatic brain injury outcome. J Neurotrauma 2007;24:1347-54.
76. Godoy DA, Pahnke P, Piñero GR, Videtta W, Aguilera S. Intensive care in severe cranioencephalic trauma. Neurociencias Colomb 2016;23:193-220.
77. Lyons MW, Blackshaw WJ. Does magnesium sulfate have a role in the management of severe traumatic brain injury in civilian and military populations? A systematic review and meta-analysis. J R Army Med Corps 2018;164:442-9.